Extended Use of The Spanner® Temporary Prostatic Stent in Catheter-Dependent Men with Comorbidities

Table 5

Pain assessment.

	1^st month of Spanner use	2^nd month of Spanner use	3^rd month of Spanner use
	n/N (%)	n/N (%)	n/N (%)
Pain with urological device (catheter or Spanner) over last 30 days
	21/93 (22.6%)	20/84 (23.8%)	16/82 (19.5%)
Frequency of pain
Less than once per week	7/21 (33.3%)	6/20 (30.0%)	5/16 (31.3%)
Several times per week	2/21 (9.5%)	4/20 (20.0%)	3/16 (18.8%)
At least once per day	5/21 (23.8%)	3/20 (15.0%)	2/16 (12.5%)
At least twice per day	4/21 (19.1%)	2/20 (10.0%)	5/16 (31.3%)
All of the time	3/21 (14.3%)	5/20 (25.0%)	1/16 (6.3%)
Pain level (1–5 scale)
Mean ± SD	2.10 ± 1.51	2.00 ± 1.38	2.50 ± 1.21
Median	1.0	1.0	3.0
Min-Max	1–5	1–5	1–5

Pain frequency and severity assessed at each study visit for all enrolled patients. Catheter-related pain was assessed at the first visit, prior to insertion of The Spanner. Spanner-related pain was assessed at each subsequent study visit, after 30 days of use.